Application
TFAP2D Antibody (C-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the TFAP2D antibody detected the TFAP2D protein (arrow).| Product Name | TFAP2D Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TFAP2BL1 |
|---|---|
| Alternative Names | TFAP2D TFAP2BL1 Transcription factor AP-2-delta Activating enhancer-binding protein 2-delta Transcription factor AP-2-beta-like 1 |
| Molecular Weight(MW) | 49578 Da |
| Function | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC (By similarity) |
| Tissue Specificity | Highly expressed in brain, placenta, skeletal muscle, thymus, small intestine, and prostate, and expressed at lower levels in leukocyte, spleen, testis, ovary and colon. Barely detectable in heart, kidney, liver, lung or pancreas |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 83741 |
|---|---|
| Nucleotide Accession | NP_758438.2 |
Application
TFAP2D Antibody (C-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the TFAP2D antibody detected the TFAP2D protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
